Children get sick. When they do, parents and pediatricians alike expect to employ just the right therapies, which often include a regimen of drugs, to treat their conditions. But are drugs known to be safe for adults, necessarily safe for children?
It has long been known that drug safety cannot be assessed based on studies with adults. So the FDA and the NIH has encouraged over the years, and even required, that clinical trials include children. But there is a right way and a wrong way to do it. The right way has to do with understanding the ethical dynamics and ensuring that all concerned understand the risks and benefits of involvement in a clinical trial.
Thomson American Health Consultants is offering an audio conference with the information necessary to help you recognize the ethical and regulatory issues related to working with children in clinical trials. Getting Assent/Parental Permission for Children Involved In Clinical Research, which will be held on Thursday, Oct. 21, 2004, from 3 p.m. to 4 p.m. EST, will be presented by Robert "Skip" Nelson, MD, PhD and Alan M. Sugar, MD.
Dr. Nelson is Associate Professor of Anesthesia & Pediatrics in the Department of Anesthesiology and Critical Care Medicine at the University of Pennsylvania School of Medicine, Children’s Hospital of Philadelphia. He also is founder of the IRB Forum. Dr. Sugar is chairman of the New England Institutional Review Board and professor of Medicine at Boston University School of Medicine.
This program will serve as an invaluable resource for your IRB coordinators, chairs, and members, as well as principal investigators and clinical trial coordinators. Your fee of $249 includes presentation materials, additional reading, and free continuing education. For more information, visit us at www.ahcpub.com, or contact customer service at (800) 688-2421 or by e-mail at email@example.com.
When registering, please reference code T04122 62762.